Zobrazeno 1 - 10
of 119
pro vyhledávání: ''
Autor:
Ernst Holler, Panagiotis Tsirigotis, Gloria Tridello, Andreas H. Groll, Emmanouil Nikolousis, Carlos Solano, Lotus Wendel, Franca Fagioli, Per Ljungman, Nicole M. A. Blijlevens, Bruno Lioure, Lidia Gil, Nina Knelange, Jiří Šrámek, Christian Junghanss, Stephan Mielke, Malgorzata Mikulska, Michael Medinger, Jan Styczyński, Federica Galaverna, Rafael de la Cámara, Aliénor Xhaard, Mervi Taskinen, Alessandra Biffi, M. Aranzazu Bermudez Rodriguez
Publikováno v:
Bone Marrow Transplantation, 56, 5, pp. 1171-1179
BONE MARROW TRANSPLANTATION
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
instname
Bone Marrow Transplantation, 56, 1171-1179
BONE MARROW TRANSPLANTATION
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
instname
Bone Marrow Transplantation, 56, 1171-1179
Letermovir (LMV) is licensed for prophylaxis of CMV infection in allogeneic hematopoietic cell transplant adult CMV-seropositive patients. Due to its favorable safety profile, LMV brings potential for use in other clinical situations, outside the app
Autor:
Sonja Genadieva Stavrik, Sascha Dietricht, Norbert Schmitz, Stephen D. Robinson, Peter Dreger, Anna Sureda, Alina Tanase, Irma Khvedelidze, Herve Finel, Olivier Hermine, Chara Kyriakou, Harry C. Schouten, Silvia Montoto, Ariane Boumendil
Publikováno v:
Bone Marrow Transplantation, 55(11), 2170-2179. Nature Publishing Group
Indications for autologous (auto-HCT) and allogeneic transplantation (allo-HCT) in relapsed/refractory Hodgkin lymphoma (rrHL) have been long established. The expectation is that long-term outcomes have significantly improved over time with increased
Autor:
Ralph Wäsch, Robert Zeiser, Hartmut Bertz, Reinhard Marks, Gabriele Ihorst, Jesus Duque-Afonso, Mehtap Yücel, Jürgen Finke, TC Köhler, Joachim Müller-Quernheim, Miguel Waterhouse
Publikováno v:
Bone Marrow Transplantation
The age of patients undergoing allogeneic hematopoietic cell transplantation (allo-HCT) has increased during the last decades, mainly due to improved reduced-intensity/toxicity conditioning protocols. A reduced-intensity conditioning based on fludara
Autor:
José Luis Piñana, Miguel A. Sanz, Guillermo Sanz, Juan Montoro, Ignacio Lorenzo, Cristina Aguado, Jaime Sanz, Luiza Tofán, Manuel Guerreiro, Eva M González Barberá, Aitana Balaguer-Roselló, María Dolores Gómez, Miguel Salavert
Publikováno v:
Bone Marrow Transplantation
Characteristics and risk factors (RFs) of community-acquired respiratory virus (CARV) infections after umbilical cord blood transplantation (UCBT) are lacking. We retrospectively analyzed CARV infections in 216 single-unit myeloablative UCBT recipien
Autor:
Herve Finel, Marrow Transplantation, Gérard Socié, Eva Domingo-Domenech, Joerg Thomas Bittenbring, Fina Climent, Peter Dreger, Frank Kroschinsky, M Stelljes, Damir Nemet, Anna Sureda, E. Vandenbergue, Stephen P. Robinson, Ariane Boumendil, Silvia Montoto
Publikováno v:
Bone Marrow Transplantation. 55:633-640
Information regarding the curative role of allogeneic stem cell transplantation (allo-HCT) in systemic anaplastic large cell lymphoma (sALCL) is scarce. We analyzed the results of allo-HCT in patients with relapsed/refractory sALCL with special empha
Autor:
Patrizia Chiusolo, Sabrina Giammarco, Carmen Di Grazia, Maria Teresa Van Lint, Federica Sorà, Andrea Bacigalupo, Emanuele Angelucci, Anna Maria Raiola, Alida Dominietto, Luca Laurenti, Francesca Gualandi
Publikováno v:
Bone Marrow Transplantation. 54:708-712
This is an update on acute and chronic graft-versus-host disease (GvHD) in 425 patients with hematologic malignancies, undergoing an unmanipulated haploidentical (HAPLO) graft from related donors, with a modified post-transplant cyclophosphamide (PT-
Autor:
Maureen Ross, Pallawi Torka, George Chen, Philip L. McCarthy, Theresa Hahn, Paul K. Wallace, Elizabeth A. Repasky, Yali Zhang, Sophia R. Balderman, Francisco J. Hernandez-Ilizaliturri, Bruno Paiva, Christine M. Ho, Joseph D. Tario, Megan M. Herr
Publikováno v:
Bone marrow transplantation
This is the first longitudinal study of immune profiles and autologous hematopoietic cell transplant (AHCT) survival in B-cell non-Hodgkin lymphoma (B-NHL) patients and the effect of plerixafor mobilization on immune reconstitution in this population
Autor:
David H. Vesole, David S. Siegel, Andrew Pecora, Alan P Skarbnik, Shijia Zhang, Joshua Richter, Scott D. Rowley, Noa Biran, Michele L. Donato
Publikováno v:
Bone Marrow Transplantation. 54:1881-1891
A regimen of escalating doses of thalidomide, in combination with bortezomib and high-dose melphalan (mel/vel/thal), was evaluated as a conditioning regimen for autologous stem cell transplantation (ASCT) in multiple myeloma (MM) patients with a prio
Autor:
Iracema Esteves, José Salvador Rodrigues de Oliveira, Juliana Folloni Fernandes, Fabio R. Kerbauy, Fabio P.S. Santos, Marcos de Lima, Nelson Hamerschlak, Adriana Seber, Borje S. Andersson
Publikováno v:
Bone Marrow Transplantation. 54:1799-1804
Busulfan is used in myeloablative schemes for hematopoietic stem cell transplantation (HSCT), with monitoring of dosage through the area under the curve (AUC) of the drug plasma concentration (µMol min). In this study, we compared the complete pharm
Autor:
Marcie L. Riches, Jaime S. Green, Maheen Z. Abidi, Dwight E Yin, Taiga Nishihori, Min Chen, Celalettin Ustun, Caroline A. Lindemans, John R. Wingard, Joshua A. Hill, Baldeep Wirk, Robert Peter Gale, Usama Gergis, Richard F. Olsson, Parameswaran Hari, Hillard M. Lazarus, Gerhard C. Hildebrandt, Jeffrey Auletta, Krishna V. Komanduri, Sachiko Seo, David Marks, Minoo Battiwala, Miguel Angel Diaz, Parastoo B. Dahi, Jean A. Yared, Soyoung Kim, Siddhartha Ganguly
Publikováno v:
Bone Marrow Transplantation, 54(8), 1354. Nature Publishing Group
Bone marrow transplantation, vol 54, iss 8
Bone marrow transplantation, vol 54, iss 8
Limited data exist on characteristics of central nervous system viruses (CNS-V) in allogeneic hematopoietic stem cell transplant (HCT) recipients. Between 2007 and 2015, the Center for International Blood and Marrow Transplant Research (CIBMTR) recei